Cardiac Arrest Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

May 2019| TMR1599A| Transparency

Report Highlights

Cardiac Arrest Treatment Market - Overview

This report analyzes the current and future scenario of the global cardiac arrest treatment market. Cardiac resynchronization therapy (CRT) has been considered the standard and most effective form of first aid in case of a sudden cardiac arrest and has been taught in classrooms and community centers across the world. Despite such popularity and awareness, CRT alone cannot save sudden cardiac arrest (SCA) victims. Majority of the people who experience sudden cardiac arrest have ventricular fibrillation (VF) which causes the heart muscles to beat rapidly and improperly in which CRT alone cannot provide effective results. The global cardiac arrest treatment market is driven by rise in chronic heart health conditions, increase in geriatric and overall population with cardiovascular disorders.

The global cardiac arrest treatment market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment, sales channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global cardiac arrest treatment market.

Global Cardiac Arrest Treatment Market: Key Segments

In terms of treatment, the global cardiac arrest treatment market has been segmented into drugs and medical devices. The drugs segment has been categorized into vasopressors, anti-arrhythmic drugs, anticholinergic drugs, corticosteroids, fibrinolytic drugs, beta blockers, and others (sodium bicarbonate, crystalloids, colloids, etc.). The medical devices segment has been classified into defibrillators, cardiac resynchronization therapy (CRT), and others. In terms of sales channel, the global cardiac arrest treatment market has been divided into hospitals, independent pharmacies, and others. The market size and forecast for each of these segments have been provided in terms of US$ Mn for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year.

Global Cardiac Arrest Treatment Market: Regional Outlook

Geographically, the global cardiac arrest treatment market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global cardiac arrest treatment market based on various attributes such as company overview, financial overview, treatment portfolio, business strategies, and recent developments. These are Amgen, Inc., Pfizer, Inc., Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Abbott, Bayer AG, Koninklijke Philips N.V., GE Healthcare, Physio-Control, Inc. (Stryker), Boston Scientific Corporation, Cardiac Science Corporation (Aurora Capital Group), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

The global cardiac arrest treatment market has been segmented as below:

Global Cardiac Arrest Treatment Market, by Treatment

Drugs
Vasopressors
Anti-arrhythmic Drugs
Anticholinergic Drugs
Corticosteroids
Fibrinolytic Drugs
Beta Blockers
Others (sodium bicarbonate, crystalloids, colloids, etc.)
Medical Devices
Defibrillators
Cardiac Resynchronization Therapy (CRT)
Others
Global Cardiac Arrest Treatment Market, by Sales Channel

Hospitals
Independent Pharmacies
Others
Global Cardiac Arrest Treatment Market, by Region

North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Prevalence Rate of Cardiac Arrest In Key Countries
  • Table 2 : Promising Treatments in Clinical Development: Cardiac Arrest, by Phase 2 Drugs
  • Table 3 : Promising Treatments in Clinical Development: Cardiac Arrest, by Phase 3 and Phase 4 Drugs
  • Table 4 : Annual cost of prehospital equipment per patient used to treat OHCA (Out- of Hospital Cardiac Arrest)
  • Table 5 : Cost incurred to cardiac arrest patients
  • Table 6 : Key Merger and Acquisition (1/2)
  • Table 7 : Key Merger and Acquisition (2/2)
  • Table 8 : Percent of Heart Failure Trials, by Phase and Location
  • Table 9 : Percent of Heart Failure Trials, by Phase and Companies
  • Table 10 : Pipeline Analysis for Cardiovascular Disorders Therapeutics (1/5)
  • Table 11 : Pipeline Analysis for Cardiovascular Disorders Therapeutics (2/5)
  • Table 12 : Pipeline Analysis for Cardiovascular Disorders Therapeutics (3/5)
  • Table 13 : Pipeline Analysis for Cardiovascular Disorders Therapeutics (4/5)
  • Table 14 : Pipeline Analysis for Cardiovascular Disorders Therapeutics (5/5)
  • Table 15 : Global Cardiac Arrest Treatment Market Size (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 16 : Global Cardiac Arrest Treatment Market Size (US$ Mn) Forecast, by Drugs,2017-2027
  • Table 17 : Global Cardiac Arrest Treatment Market Size (US$ Mn) Forecast, by Medical Devices,2017-2027
  • Table 18 : Global Cardiac Arrest Treatment Market Size (US$ Mn) Forecast, by Sales Channel,2017-2027
  • Table 19 : Global Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Region,2017-2027
  • Table 20 : North America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Country,2017-2027
  • Table 21 : North America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 22 : North America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Drugs,2017-2027
  • Table 23 : North America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Medical Devices,2017-2027
  • Table 24 : North America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Sales Channel,2017-2027
  • Table 25 : Europe Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 26 : Europe Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 27 : Europe Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Drugs,2017-2027
  • Table 28 : Europe Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Medical Devices,2017-2027
  • Table 29 : Europe Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Sales Channel,2017-2027
  • Table 30 : Asia Pacific Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 31 : Asia Pacific Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 32 : Asia Pacific Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Drugs,2017-2027
  • Table 33 : Asia Pacific Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Medical Devices,2017-2027
  • Table 34 : Asia Pacific Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Sales Channel,2017-2027
  • Table 35 : Latin America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 36 : Latin America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 37 : Latin America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Drugs,2017-2027
  • Table 38 : Latin America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Medical Devices,2017-2027
  • Table 39 : Latin America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Sales Channel,2017-2027
  • Table 40 : Middle East & Africa Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 41 : Middle East & Africa Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 42 : Middle East & Africa Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Drugs,2017-2027
  • Table 43 : Middle East & Africa Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Medical Devices,2017-2027
  • Table 44 : Middle East & Africa Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Sales Channel,2017-2027
  • Figure 1 : Global Cardiac Arrest Treatment Market Size (US$ Mn), 2017 and 2026
  • Figure 2 : Global Cardiac Arrest Treatment Market Snapshot
  • Figure 3 : Global Cardiac Arrest Treatment Market Size (US$ Mn) Forecast,2017-2027
  • Figure 4 : Global Cardiac Arrest Treatment Market
  • Figure 5 : Global Cardiac Arrest Treatment Market
  • Figure 6 : Global Cardiac Arrest Treatment Market
  • Figure 7 : Global Cardiac Arrest Treatment Market
  • Figure 8 : Global Cardiac Arrest Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 9 : Global Cardiac Arrest Treatment Market Value Share Analysis, by Drugs, 2018 and 2027
  • Figure 10 : Global Cardiac Arrest Treatment Market Value Share Analysis, by Medical Devices, 2018 and 2027
  • Figure 11 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn) Forecast, by Vasopressors,2017-2027
  • Figure 12 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Anti-arrhythmic Drugs,2017-2027
  • Figure 13 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn) Forecast, by Anticholinergic Drugs,2017-2027
  • Figure 14 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Corticosteroids,2017-2027
  • Figure 15 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn) Forecast, by Fibrinolytic Drugs,2017-2027
  • Figure 16 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Beta Blockers,2017-2027
  • Figure 17 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Others,2017-2027
  • Figure 18 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn) Forecast, by Defibrillators,2017-2027
  • Figure 19 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Cardiac Resynchronization Therapy (CRT),2017-2027
  • Figure 20 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Others,2017-2027
  • Figure 21 : Global Cardiac Arrest Treatment Market Attractiveness Analysis, by Drugs, 2017–2025
  • Figure 22 : Global Cardiac Arrest Treatment Market Attractiveness Analysis, by Medical Devices, 2017-2025
  • Figure 23 : Global Cardiac Arrest Treatment Market Value Share Analysis, by Sales Channel, 2017 and 2025
  • Figure 24 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Hospital,2017-2027
  • Figure 25 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Independent Pharmacies,2017-2027
  • Figure 26 : Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Others,2017-2027
  • Figure 27 : Global Cardiac Arrest Treatment Market Attractiveness Analysis, by Sales Channel 2017–2025
  • Figure 28 : Global Cardiac Arrest Treatment Market Value Share, by Region, 2018 and 2027
  • Figure 29 : Global Cardiac Arrest Treatment Market Attractiveness, by Region, 2019–2027
  • Figure 30 : North America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, 2019–2027
  • Figure 31 : North America Cardiac Arrest Treatment Market Value Share, by Country, 2018 and 2027
  • Figure 32 : North America Cardiac Arrest Treatment Market Attractiveness, by Country, 2019–2027
  • Figure 33 : North America Cardiac Arrest Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 34 : North America Cardiac Arrest Treatment Market Attractiveness, by Treatment, 2019–2027
  • Figure 35 : North America Cardiac Arrest Treatment Market Value Share Analysis, by Drugs, 2018 and 2027
  • Figure 36 : North America Cardiac Arrest Treatment Market Value Share Analysis, by Medical Devices, 2018 and 2027
  • Figure 37 : North America Cardiac Arrest Treatment Market Value Share Analysis, by Sales Channel, 2018 and 2027
  • Figure 38 : North America Cardiac Arrest Treatment Market Attractiveness, by Sales Channel, 2019–2027
  • Figure 39 : Europe Cardiac Arrest Treatment Market Value (US$ Mn) Forecast,2017-2027
  • Figure 40 : Europe Cardiac Arrest Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 41 : Europe Cardiac Arrest Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 42 : Europe Cardiac Arrest Treatment Market Value Share, by Treatment, 2018 and 2027
  • Figure 43 : Europe Cardiac Arrest Treatment Market Attractiveness, by Treatment, 2019–2027
  • Figure 44 : Europe Cardiac Arrest Treatment Market Value Share, by Drugs, 2018 and 2027
  • Figure 45 : Europe Cardiac Arrest Treatment Market Value Share, by Medical Devices, 2018 and 2027
  • Figure 46 : Europe Cardiac Arrest Treatment Market Value Share, by Sales Channel, 2018 and 2027
  • Figure 47 : Europe Cardiac Arrest Treatment Market Attractiveness, by Sales Channel, 2019–2027
  • Figure 48 : Asia Pacific Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, 2019–2027
  • Figure 49 : Asia Pacific Cardiac Arrest Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 50 : Asia Pacific Cardiac Arrest Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 51 : Asia Pacific Cardiac Arrest Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 52 : Asia Pacific Cardiac Arrest Treatment Market Attractiveness, by Treatment, 2019–2027
  • Figure 53 : Asia Pacific Cardiac Arrest Treatment Market Value Share Analysis, by Drugs, 2018 and 2027
  • Figure 54 : Asia Pacific Cardiac Arrest Treatment Market Value Share Analysis, by Medical Devices, 2018 and 2027
  • Figure 55 : Asia Pacific Cardiac Arrest Treatment Market Value Share Analysis, by Sales Channel, 2018 and 2027
  • Figure 56 : Asia Pacific Cardiac Arrest Treatment Market Attractiveness, by Sales Channel, 2019–2027
  • Figure 57 : Latin America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast,2017-2027
  • Figure 58 : Latin America Cardiac Arrest Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 59 : Latin America Cardiac Arrest Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 60 : Latin America Cardiac Arrest Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 61 : Latin America Cardiac Arrest Treatment Market Attractiveness, by Treatment, 2019–2027
  • Figure 62 : Latin America Cardiac Arrest Treatment Market Value Share Analysis, by Drugs, 2018 and 2027
  • Figure 63 : Latin America Cardiac Arrest Treatment Market Value Share Analysis, by Medical Devices, 2018 and 2027
  • Figure 64 : Latin America Cardiac Arrest Treatment Market Value Share Analysis, by Sales Channel, 2018 and 2027
  • Figure 65 : Latin America Cardiac Arrest Treatment Market Attractiveness, by Sales Channel, 2019–2027
  • Figure 66 : Middle East & Africa Cardiac Arrest Treatment Market Value (US$ Mn) Forecast,2017-2027
  • Figure 67 : Middle East & Africa Cardiac Arrest Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 68 : Middle East & Africa Cardiac Arrest Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 69 : Middle East & Africa Cardiac Arrest Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 70 : Middle East & Africa Cardiac Arrest Treatment Market Attractiveness, by Treatment, 2019–2027
  • Figure 71 : Middle East & Africa Cardiac Arrest Treatment Market Value Share Analysis, by Drugs, 2018 and 2027
  • Figure 72 : Middle East & Africa Cardiac Arrest Treatment Market Value Share Analysis, by Medical Devices, 2018 and 2027
  • Figure 73 : Middle East & Africa Cardiac Arrest Treatment Market Value Share Analysis, by Sales Channel, 2018 and 2027
  • Figure 74 : Middle East & Africa Cardiac Arrest Treatment Market Attractiveness, by Sales Channel, 2019–2027
  • Figure 75 : Global Cardiac Arrest Treatment Drugs Market Share Analysis, by Company (2018)
  • Figure 76 : Global Cardiac Arrest Treatment Medical Devices Market Share Analysis, by Company (2018)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report